My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Surya Industrial Corporation to hold AGM

Surya Industrial Corporation to hold AGM

Sep 14,2016

Surya Industrial Corporation announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2016.

Powered by Capital Market - Live News

HeidelbergCement India hardens after strong Q4 results
May 26,2017

The result was announced after market hours yesterday, 25 May 2017.

The stock had risen 3.49% to Rs 124.70 yesterday, 25 May 2017 ahead of the results.

Meanwhile, the S&P BSE Sensex was up 245.97 points or 0.8% at 30,996. The S&P Small-Cap index was up 209.96 points or 1.41% at 15,058.69.

On the BSE, 62,676 shares were traded in the counter so far as against average daily volume of 69,326 shares in the past one quarter.

The stock had hit a high of Rs 130.65 and a low of Rs 126.50 so far during the day. The stock had hit a 52-week high of Rs 150.55 on 28 October 2016. The stock had hit a 52-week low of Rs 94.25 on 25 May 2016. The stock had underperformed the market over the past one month till 25 May 2017, dropping 7.53% compared with 2.69% rise in the Sensex. The scrip, had, however, outperformed the market in past one quarter, gaining 7.36% as against Sensexs 6.43% rise.

The small-cap cement manufacturing company has equity capital of Rs 226.62 crore. Face value per share is Rs 10.

HeidelbergCement India said that the board of directors recommended a dividend of Rs 2 per share for the financial year ended 31 March 2017 (FY 2017).

HeidelbergCement India is a subsidiary of HeidelbergCement Group, Germany. The company has its operations in Central India at Damoh (Madhya Pradesh), Jhansi (Uttar Pradesh) and in Southern India at Ammasandra (Karnataka).

Powered by Capital Market - Live News

Govt. to set up state cancer institutes each costing Rs. 100 cr: Anupriya Patel, MoS, Health & Family Welfare
May 26,2017

Government has recently approved a scheme for enhancing the Tertiary Care Cancer facilities in the country under NPCDCS to grant financial assistance to 20 State Cancer Institutes and 50 Tertiary Cancer Care Centres in different parts of the country, Ms Anupriya Patel, Minister of State for Health & Family Welfare said at an ASSOCHAM event.

The prevalence of hypothyroidism in India is 11%, compared to only 2% in the United Kingdom and 4.6% in the United States of America. Compared with coastal cities like Mumbai, Goa and Chennai, cities located inland like Kolkata, Delhi, Ahmadabad, Bangalore and Hyderabad have a higher prevalence,n++ said Ms Anupriya Patel.

n++Todays India is a young India, where people are willing to work hard with an assurance of being masters of their own destiny. I would like to mention here that India is a signatory to the 2030 agenda for Sustainable Development and is committed to achieve the SDGs including SDG-3 to Ensure healthy lives and promote well-being for all at all ages. The new National Health Policy, 2017 which got approval by the union cabinet recently, envisages to attain the highest possible level of good health and well-being, through a preventive and promotive health care orientation in all developmental policies, and universal access to good quality health care services without anyone having to face financial hardship. This would be achieved through increasing access, improving quality and lowering the cost of healthcare delivery.

The policy, while supporting the need for moving in the direction of a right based approach to healthcare is conscious of the fact that threshold levels of finances and infrastructure is a precondition for an enabling environment, to ensure that the poorest of the poor stand to gain the maximum and are not embroiled in legalities. The policy therefore advocates a progressively incremental assurance based approach, with assured funding to create an enabling environment for realizing health care as a right in the future,n++ said Ms Anupriya Patel.

She further said that currently, women in India, like in other South East Asian countries, face numerous health issues, which ultimately affect their aggregate economic output. We all know that women are pivotal contributors to society in their roles as mothers, sisters, family members, and as socially responsible citizens. Addressing the gender, class or ethnic disparities that exist in healthcare and improving the health outcome, can contribute to women empowerment and socio-economic gain.

n++Between 30-50% of cancers can currently be prevented. This can be accomplished by avoiding risk factors and implementing existing evidence-based prevention strategies. Many cancers have a high chance of cure if diagnosed early and treated adequately. So, the key to survival is prevention, early detection, and proper cure which are possible only with proper awareness among people. Not only the Government, but also private players and NGOs have a great role in creating awareness on the preventive care and symptoms of these diseases. Cancer burden can thus be reduced through early detection and management,n++ added the minister.

n++Determining the goals of treatment and palliative care is an important first step, and health services should be integrated and people-centred. The primary goal is generally to cure cancer or to considerably prolong life. Improving the patients quality of life is also an important goal. This can be achieved by supportive or palliative care and psycho-social support,n++ further said Ms Patel.

Awareness for prevention of cancer and early detection of cancer is being carried out at all levels through NCD clinics at Districts & CHC levels. However higher level facilities for Surgery, chemotherapy & supportive care are available only at District Hospitals. I am told that 388 district NCD clinics and 2115 CHC NCD clinics are functional in the country as on March 2017, said Ms. Patel.

In India, million people suffer from thyroid diseases. There is a high burden of thyroid disorders in India due to endemic iodine deficiency and scarcity of proper therapeutic resources. Thyroid disorders are more common in women than men with the prevalence of 664% and 33.6% respectively, reveals the ASSOCHAM-Turacoz joint paper coinciding with the n++World Thyroid Dayn++ (May 25) noted.

Thyroid disorder is another area affecting womens health. Common manifestations of thyroid disease in women reportedly include hypothyroidism, hyperthyroidism, and thyroid cancers. Hypothyroidism and hyperthyroidism are about 10 times more prevalent in women than in men. Unfortunately, awareness about the disease and its diagnosis remain shockingly low and there is a pressing need to reach out and make women aware of the causes, symptoms, treatment and importance of screening for thyroid problems.

Powered by Capital Market - Live News

Volumes jump at Swelect Energy Systems counter
May 26,2017

Swelect Energy Systems clocked volume of 1.28 lakh shares by 13:55 IST on BSE, a 115.02-times surge over two-week average daily volume of 1,000 shares. The stock zoomed by 20% upper circuit level at Rs 421.35 after the company reported net profit of Rs 13 crore in Q4 March 2017, compared with net loss of Rs 1.04 crore in Q4 March 2016. Total income rose 95.67% to Rs 91.75 crore in Q4 March 2017 over Q4 March 2016.

Healthcare Global Enterprises notched up volume of 2.52 lakh shares, a 96.13-fold surge over two-week average daily volume of 3,000 shares. The stock lost 0.67% at Rs 251.05.

Marico saw volume of 31.67 lakh shares, a 33.11-fold surge over two-week average daily volume of 96,000 shares. The stock was down 0.1% at Rs 314.85.

Banco Products (India) clocked volume of 18.73 lakh shares, a 24.25-fold surge over two-week average daily volume of 77,000 shares. The stock advanced 3.76% at Rs 225.

Sequent Scientific saw volume of 10.41 lakh shares, a 19.3-fold rise over two-week average daily volume of 54,000 shares. The stock was up 3.11% at Rs 116.

Powered by Capital Market - Live News

Central Board of Direct Taxes (CBDT) Issues Clarification on furnishing Statement of Financial Transaction (SFT) & SFT Preliminary Response
May 26,2017

Section 285BA of the Income-tax Act, 1961 requires furnishing of a Statement of Financial Transaction (SFT) for transactions prescribed under Rule 114E of the Income-tax Rules, 1962. The due date for filing such SFT in Form 61A is 31st May 2017.

In case there are reportable transactions for the year, the reporting person/entity is required to register with the Income Tax Department and generate Income Tax Department Reporting Entity Identification Number (ITDREIN). The same can be generated by logging-in to the e-filing website (https://incometaxindiaefiling.gov.in/) with the login ID used for the purpose of filing the Income Tax Return of the reporting person / entity. Entity having PAN can take only PAN based ITDREIN. Entity having TAN can generate an ITDREIN only when such TANs Organisational PAN is not available.

The registration of reporting person (ITDREIN registration) is mandatory only when at least one of the Transaction Type is reportable. A functionality SFT Preliminary Response has been provided on the e-Filing portal for the reporting persons to indicate that a specified transaction type is not reportable for the year.

Detailed procedure of ITDREIN registration and upload of Form 61A is available under the n++Helpn++ section and Form 61A utility and Schema are available under the download section of http://www.incometaxindiaefiling.gov.in and https://www.cleanmoney.gov.in. Online filing of form 61A requires a valid class 2 or 3 digital signature certificate of person responsible for filing the same. Please refer n++DSC Management Utilityn++ manual under help section on how to generate the signature file, attaching the XML with signature and uploading of XML with signature file in e-Filing portal.

Powered by Capital Market - Live News

Jaiprakash Power Ventures provides update on Bara STP project
May 26,2017

Jaiprakash Power Ventures announced the third unit of 660 MW of Bara Super Critical Thermal Power Project (BSTPP) implemented by Prayagraj Power Generation Company (PPGCL), (a material unlisted subsidiary of the Company) has successfully commenced commercial operation at 0.00 hours on 26 May, 2017. With this, 1980 MW BSTPP of PPGCL stands fully commenced.

Powered by Capital Market - Live News

HDFC Bank allots 3909200 equity shares
May 26,2017

HDFC Bank has has allotted on 26 May 2017, 3909200 equity shares to the employees of the Bank pursuant to exercise of options under its Employees Stock Options Schemes (ESOS).

The paid up share capital of the Bank will accordingly increase from Rs. 5129818234 equity shares of Rs 2/- each to Rs. 5137636634 equity shares of Rs 2/- each.

Powered by Capital Market - Live News

Ujaas Energy secures order for solar PV plant
May 26,2017

Ujaas Energy has received a letter of intent from Arunachal Pradesh Energy Development Agency for design, supply, installation, testing and commissioning of 200 kwp Grid Connected Solar PV Plant at the State Assembly Building, Itanagar, Arunachal Pradesh.

Powered by Capital Market - Live News

Tera Software appoints company secretary
May 26,2017

Tera Software has appointed B.Sowmya as Company Secretary & Compliance Officer of the Company.

Powered by Capital Market - Live News

Atal Pension Yojana (APY) reaches 53 lakhs subscribers base
May 26,2017

The subscribers base under the Atal Pension Yojana (APY) has reached about 53 Lakhs. At present 235 Banks and Department of Post are involved with the implementation of the scheme. Besides the branches of the banks and CBS-enabled offices of India Post, quite a few banks are sourcing subscribers through their internet banking portals in a paperless environment.

The APY Scheme follows the same investment pattern as applicable to the NPS contribution of Central Government employees. During the year 2016-17, it has earned a return of 13.91%.

With a view to empower the APY subscribers, new functionalities have been developed where under a subscriber can view and print the ePRAN card and Statement of Transactions.

Presently males account for 62% of the subscribers and female for about 38%. Most of the subscribers have opted for monthly contribution; about 97.5% of the subscribers are contributing at monthly intervals, about 0.8% at quarterly intervals and about 1.7% at half yearly intervals.

A majority of the subscribers have opted for a monthly pension of Rs. 1000/-. Presently 51.5% subscribers have opted for a monthly pension of Rs.1000/- and 34.5% of the subscribers have opted for a monthly pension of Rs.5000.

Powered by Capital Market - Live News

Cheviot Company fixes record date for dividend
May 26,2017

Cheviot Company has fixed 16 June 2017 as record date for payment of dividend.

Powered by Capital Market - Live News

Indoco Remedies to pay dividend
May 26,2017

Indoco Remedies announced that dividend, if declared will be dispatched on or after 14 August 2017.

Powered by Capital Market - Live News

Lupin extends recent losses
May 26,2017

Meanwhile, the S&P BSE Sensex was up 216.99 points or 0.71% at 30,967.02.

On the BSE, 1.14 lakh shares were traded on the counter so far as against the average daily volumes of 1.48 lakh shares in the past two weeks. The stock hit a high of Rs 1,163.60 and a low of Rs 1,115 so far during the day.

The stock had hit a 52-week high of Rs 1,750 on 29 July 2016 and 52-week low of Rs 1,108 on 25 May 2017.

The large-cap company has equity capital of Rs 90.33 crore. Face value per share is Rs 2.

Shares of Lupin have fallen 8.76% in two trading sessions from its closing of Rs 1,227.65 on 24 May 2017, on reports that a foreign brokerage has downgraded the stock to outperform from buy earlier and has also lowered its target price to Rs 1,350 from Rs 1,760 earlier.

According to reports, the global brokerage stated that Lupin expects a challenging FY 2018 due to competitive/regulatory pressures in the US and Japan. US concerns are on account of continued customer consolidation, incremental competition in top products, and slower-than-expected Gavis ramp-up, it said. The brokerage further added that a few critical FY 2019 launches of the company have been pushed out to FY 2020.

Shares of Lupin had fallen 1.71% to settle at Rs 1,227.65 on 24 May 2017 after the company announced weak Q4 earnings during market hours on that day.

Lupins consolidated net profit fell 49.16% to Rs 380.21 crore on 1.33% growth in total revenue from operations to Rs 4253.30 crore in Q4 March 2017 over Q4 March 2016.

During Q4 March 2017, the company made a provision for liability towards its Australian subsidiary amounting to Rs 155.90 crore in respect of compensation for patent litigation towards its Isabelle generic launch in Australia.

Lupins shares witnessed selling pressure in the run-up to the announcement of its Q4 results. They had fallen 5.01% in two trading sessions to settle at Rs 1,249 on 23 May 2017, from its closing of Rs 1,314.90 on 19 May 2017.

Lupin is a pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Powered by Capital Market - Live News

Dr Reddys gets healthier after USFDA clears plant after audit
May 26,2017

The announcement was made after market hours yesterday, 25 May 2017.

Meanwhile, the S&P BSE Sensex was up 179.53 points, or 0.63% to 30,945.12.

The stock had dropped 11.15% in six sessions to Rs 2,427.30 yesterday, 25 May 2017 from a close of Rs 2,731.95 on 17 May 2017.

On the BSE, 24,482 shares were traded in the counter so far, compared with average daily volumes of 40,962 shares in the past one quarter.

At the days high of Rs 2,548.75 hit in early trade, the stock had jumped 5%. The stock had hit a low of Rs 2,431.15 so far during the day. The stock had hit a 52-week high of Rs 3,689 on 20 July 2016 and a 52-week low of Rs 2,400 yesterday, 25 May 2017.

The stock had underperformed the market over the past one month till 25 May 2017, dropping 8.25% compared with 2.69% rise in the Sensex. The scrip also underperformed the market in past one quarter, declining 16.01% as against Sensexs 6.43% rise.

The large-cap drug major has equity capital of Rs 82.87 crore. Face value per share is Rs 5.

Dr Reddys Laboratories said that the United States Food & Drug Administration (USFDA) completed the audit of its formulations Srikakulum plant (SEZ) unit II, in Andhra Pradesh on 25 May 2017 with zero observations.

Dr Reddys Laboratories consolidated net profit rose 175.4% to Rs 337.60 crore on 5.4% decline in net sales to Rs 3554.20 crore in Q4 March 2017 over Q4 March 2016.

Dr Reddys Laboratories is an integrated global pharmaceutical company.

Powered by Capital Market - Live News

SI Capital & Financial Services to hold board meeting
May 26,2017

SI Capital & Financial Services will hold a meeting of the Board of Directors of the Company on 29 May 2017, to consider, approve and take on record the Audited Financial Results of the company for the quarter and year ended 31st March 2017.

Powered by Capital Market - Live News

SFL International to hold board meeting
May 26,2017

SFL International will hold a meeting of the Board of Directors of the Company on 30 May 2017, to consider, approve and sign the Standalone Audited Financial Results of the Company, for the last quarter and financial ended on 31st day of March, 2017, and others.

Powered by Capital Market - Live News